•Pedlar C, Stanley N, Halson SL, et alReversing the state of arousal and accelerating sleep onset: pharmacological and non-pharmacological manipulation of sleep in athletes British Journal of Sports Medicine Published Online First: 28 August 2023. doi: 10.1136/bjsports-2023-107201 •Stanley N, (2023)The Future of Sleep Staging, Revisited, Nature and Science of Sleep 2023:15 313–322 Read•Groeger JA, Stanley N, Deacon S, Dijk DJ (2014) Dissociating effects of global SWS disruption and healthy ageing on waking performance and daytime sleepiness. Sleep 37(6): 1127–1142.•Fischer J, Dogas Z, Bassetti CL, Berg S, Grote L, Jennum P, Levy P, Mihaicuta S, Nobili L, Riemann D, Puertas Cuesta FJ, Raschke F, Skene DJ, Stanley N, Pevernagie D; Executive Committee (EC) of the Assembly of the National Sleep Societies (ANSS); Board of the European Sleep Research Society (ESRS), Regensburg, Germany. (2012) Standard procedures for adults in accredited sleep medicine centres in Europe. Journal of Sleep Research 21(4):357-68 Read•Stanley N. (2012) Importance of sleep in neuropathic pain; Bedeutung des Schlafs bei neuropathischen Schmerzen. Somnologie - Schlafforschung und Schlafmedizin 16(1) 17-19•Dijk DJ, Stanley N, Lundahl J, Groeger JA, Legters A, Trap Huusom AK, Deacon S. (2012) Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia. Journal of Psychopharmacology 26(8):1096-1107.•Boyle J, Stanley N, James L, Wright N, Johnsen S, Arbon EL, Dijk, DJ (2011) Acute sleep deprivation: the effects of the AMPAKINE compound, CX717, on human cognitive performance, alertness and recovery sleep. Journal of Psychopharmacology 26(8):1047-57. Read•van Kerrebroeck P, Hashim H, Holm-Larsen T, Robinson D, Stanley N (2010) Thinking beyond the bladder: antidiuretic treatment of nocturia The International Journal of Clinical Practice 64(6): 807-16 Read•Dijk DJ, Groeger JA, Stanley N, Deacon S. (2010) Age-related reduction in daytime sleep propensity and nocturnal slow wave sleep. Sleep 33(2) 211-23 Read•Pevernagie D, Stanley N, Berg S, Krieger J, Amici R, Bassetti C, Billiard M, Cirignotta F, Garcia-Borreguero D, Tobler I, Fischer J; Task Force of the European Sleep Research Society.(2009) European guidelines for the certification of professionals in sleep medicine: report of the task force of the European Sleep Research Society. Journal of Sleep Research 18(1) 136-41 Read•Meadows R, Arber S, Venn S, Hislop J, Stanley N. (2009) Exploring the interdependence of couples' rest-wake cycles: an actigraphic study. Chronobiology International 26(1) 80-92 Read•Dawson J, Boyle J, Stanley N, Johnsen S, Hindmarch I, Skene DJ. (2008) Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance. Human Psychopharmacolology 23(7) 605-13. Read•Pedlar CR; Lane AM, Lloyd JC, Dawson J, Emegbo S, Whyte GP, Stanley N (2007) Sleep Profiles and Mood States During an Expedition to the South Pole Wilderness and Environmental Medicine 18(2) 127-132 Read•Schneider T, Stanley N (2007) Impact of Nocturia on Sleep and Energy European Urology Supplements 6 (9) 585-593 Read•Hindmarch I, Legangneux E, Stanley N, Emegbo S, Dawson J. (2006) A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. British Journal of Clinical Pharmacology 62(5):538-45 Read•Boyle J, Eriksson M, Stanley N, Fujita T Kumagi Y (2006) Allergy Medication in Japanese Volunteers: A 3-way cross over study to assess treatment effect of single doses on nocturnal sleep architecture and next day residual effects. Current Medical Research and Opinion 22(7):1343-51•Cropley M, Dijk D-J. Stanley N. (2006) Job strain, work rumination and sleep in school teachers. European Journal of Work and Organizational Psychology 15(2):181-196 Read•Pevernagie D, Stanley N, Berg S, Krieger J, Fischer J (2006) European guidelines for the accreditation of Sleep Medicine Centres. Journal of Sleep Research 15 231-238 Read•Meadows R, Venn S, Hislop J, Stanley N, Arber S. (2005) Investigating couples’ sleep: an evaluation of actigraphic analysis techniques. Journal of Sleep Research 14 377-386 Read•Stanley N. (2005) The underestimated impact of nocturia on quality of life. European Urology Supplements 4 (7) 17-20 Read•Pedlar C, Whyte G, Emegbo S, Stanley N, Hindmarch I, Godfrey R. (2005). Acute sleep responses in a normobaric hypoxic tent. Medicine and Science in Sports and Exercise 37 (6):1075-1079. Read•Hindmarch I, Dawson J, Stanley, N. (2005) A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 28 (2) 187-193 Read•Stanley, N. (2005). The physiology of sleep and the impact of aging. European Urology Supplements 3 (6) 17-23 Read•Dawson J, Stanley N, Hindmarch I. (2004).The use of non-invasive monitoring methods (for human exposure) with Actigraphs. Aspects of Applied Biology 71 Vol. II, International advances in pesticide application. 393-397•Trick L., Stanley N, Rigney U, Hindmarch I. (2004): A double-blind, randomised 26-week study comparing the cognitive and psychomotor effects and efficacy of 75mg (37.5mg b.i.d) venlafaxine and 75mg (25mg mane, 50mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice. Journal of Psychopharmacology 18 (2) 205-214•Stanley N (2003) Actigraphy in human psychopharmacology: a review Human Psychopharmacology: Clinical & Experimental 18 (1) 39-58.•Hindmarch I, Patat A, Stanley N, Paty I, Rigney U. (2001) Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hours before awakening. Human Psychopharmacology, 16 159-167•Hindmarch I., Rigney U, Stanley N, Quinlan P, Rycroft J, Lane, J. (2000) A naturalistic investigation of the effects of day long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology, 149, 203-216.•Hindmarch I, Rigney U, Stanley N, Briley M. (2000) Pharmacodynamics of milnacipran in young and elderly volunteers. British Journal of Pharmacology 49 118-125 Read•Hindmarch I., Cockle SM, Stanley N. (1999). The anatomy of a clinical trial Human Psychopharmacology, 14 S103-108•Fairweather DB, Stanley N, Yoon JS, Hindmarch I. (1999) The effects of fluoxetine and dothiepin on cognitive function in depressed patients in general practice. Human Psychopharmacology 14 325-332•Hindmarch I, Shamsi Z, Stanley N, Fairweather DB, (1999) A double-blind, placebo controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognition and psychomotor function. British Journal of Pharmacology 48 200-206 Read•Stanley N, Fairweather DB, Hindmarch, I. (1999) The effects of fluoxetine and dothiepin on twenty four hour activity in depressed patients. Neuropsychobiology 39:44-48•Parkin C, Fairweather, DB, Shamsi Z, Stanley N, Hindmarch I. (1998). The effects of cigarette smoking on overnight performance. Psychopharmacology, 136 172-178•Stanley N, Hindmarch I (1997) Actigraphy can measure antidepressant induced daytime sedation in healthy volunteers Human Psychopharmacology, 12 437-443.•Stanley N. (1996). The future of sleep staging. Human Psychopharmacology, 11 (3) 253-257.•Shamsi Z, Stanley N, Yoon J, Hindmarch I. (1996) Effects of 3 doses of 3-Indole Pyruvic Acid on subjective and objective measures of sleep & morning after performance. Human Psychopharmacology, 11 (3) 235-241.•Stanley N, Alford CA, Rombaut NEI, Hindmarch I. (1996) Comparison of the effects of Astemizole / Pseudoephedrine and Triprolidine / Pseudoephedrine on CNS activity and psychomotor function. International Clinical Psychopharmacology, 11 (1) 31-37Scientific Book Chapters•Hough P., Haun C., Stanley N, Tumminello N. (2022) Health and Fitness Assessment. in Advanced Personal Training Science to Practice 2nd Edition. Hough P Schoenfeld BJ. (Eds) Routledge, Abingdon Chapter 5 pp64-81•Stanley N (2012) Impact of Nocturia on Quality of Sleep. In: Current Aspects on Diagnosis and Treatment of Nocturia. Oelke, M, van Kerrebroek P., (Eds) Uni-Med Velag, Bremen. chapter 4.1 pp 56-60•Stanley N (1997) Actigraphy in Psychopharmacology. In: Human Psychopharmacology, Methods and Measures Vol. 6. Hindmarch, I., Stonier, P.D., (Eds), John Wiley & Sons, Chichester. chapter 5 pp 67-91Book Chapter‘Women and Sleep’ in The Female Mind: A User's Guide, Kathryn M. Abel and Rosalind Ramsay (Eds.) Chapter 15 Royal College of PsychiatristshereBook ContributionThe 10-minute consultation: persistent pain (2015) Johnson M., Taylor A. (Eds) Cedilla Publishing Ltd, London
Published Abstracts
•Hindmarch I, Legangneux E, Stanley N. (2004) A randomised double-blind placebo-controlled 10-way cross-over study shows that a new zolpidem modified release formulation improves sleep maintenance compared to standard zolpidem. Sleep27 A55•Meadows R, Diaper A, Stanley N, Hindmarch, I. (2004) Later life and the use of sleep aids: Results from a large scale UK survey. International Journal of Neuropsychopharmacology, 7 (1) S453•Emegbo S, Stanley N, Hindmarch I. (2004). An experimental method of evaluating duration of hypnotic effect.International Journal of Neuropsychopharmacology 7 (1) S456•Emegbo S, Pedlar C, Stanley N, Whyte G. (2003) Acute normobaric hypoxia and its effects on measures of sleep quality in recreational athletes. Medicine and Science in Sports and Exercise35(Suppl) s162:891•Stanley N, Emegbo S, Pedlar C, Whyte G. (2003) Nocturnal respiratory events during sleep in acute normobaric hypoxia in recreational athletes. Medicine and Science in Sports and Exercise35 (Suppl):s162; 892•Degia A, Emegbo S, Stanley N, Pedlar C, Whyte G. (2003) Effect of acute normobaric hypoxia on cognitive and psychomotor function in recreational athletes. Medicine and Science in Sports and Exercise, 35(Suppl) s162:893 •Pedlar C, Whyte G, Dawson J, Emegbo S, Stanley N. (2003) Sleep characteristics in acute normobaric hypoxia in recreational athletes. High Altitude Medicine and Biology, 3(Suppl) s29•Cropley M, Dijk D, Stanley N. The effects of rumination about work issues during leisure time on sleep: A two day diary study. Sleep, 26(Suppl 2) A306•Emegbo S, Stanley N, Pedlar C, Hindmarch I, Whyte G. (2003) Nocturnal respiratory events during sleep at a simulated altitude of 2,500m in recreational athletes. Sleep, 26(Suppl 2) A251•Emegbo S, Stanley N, Hindmarch I. (2003) Central arousal response to an experimental model of sleep disruption in healthy adults. Sleep, 26(Suppl 2) A194•Hindmarch I, Dawson J, Stanley N. (2003) Evaluation of the sleep-activity profile of pregabalin compared with alprazolam in normal volunteers. Sleep, 26(Suppl 2) A86•Stanley N, Emegbo S, Pedlar C, Whyte G, Hindmarch I. (2003) Acute normobaric hypoxia and its effects on measures of sleep quality in recreational athletes. Sleep, 26 (Suppl 2) A70•Hindmarch I, Dawson J, Stanley N. (2003) Evaluation of cognitive and psychomotor profile of pregabalin in normal volunteers. The Journal of Pain, 4, 84.•Hindmarch I, Dawson J, Stanley N. (2002) Evaluation of sleep-activity profile of pregabalin compared to alprazolam in normal volunteers. International Journal of Neuropsychopharmacology. 2(suppl. 1) S133-4•Hindmarch I, Dawson J, Stanley N. (2002) Evaluation of cognitive and psychomotor profile of pregabalin compared to alprazolam in normal volunteers. International Journal of Neuropsychopharmacology. 5(suppl. 1) S133•Stanley N, Hindmarch I. (2001) Actigraphy as a measure of daytime sedation. Klinische Neurophysiologie3249•Hindmarch I., Stanley N, Rigney U. (2001) Pharmacodynamics of zaleplon: the first non-sedating hypnotic. Klinische Neurophysiologie32 53•Alford C. Hindmarch I, Stanley N, Yorke, L. (2000) Cognitive and sleep effects of antihistamines: Human studies.European Neuropsychopharmacology10 (suppl. 3) S202•Hindmarch I, Stanley, N, Paty I. Patat A. (2000) Comparison of the residual effects of zaleplon and zolpidem after administration during the night.European Neuropsychopharmacology10 (suppl. 3) S394•Stanley N, Dorling MC, Dawson J, Hindmarch I. (2000). Theaccuracy of Mini-Motionlogger and Actiwatch in the identification of sleep as compared to sleep EEG. Sleep, 23(Suppl 2) A386•Stanley N, Hindmarch I.(1999) Moclobemide and sleep.European Neuropsychopharmacology9 (suppl. 5) S363•Stanley N, Dawson J, Hindmarch I.(1999). The measurement of daytime ‘sleep -like’ activity using actigraphs.European Neuropsychopharmacology9 (suppl. 5) S226•Shamsi Z, Stanley N, Fairweather DB, Hindmarch I. (1999). The effects of fexofenadine on cognitive function and psychomotor performance. The International Journal of Neuropsychopharmacology. 2 (suppl. 1) S245•Rigney U, Stanley, N, Quinlan P, Rycroft J, Lane, J, Hindmarch I. (1999) The effects of day long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. The International Journal of Neuropsychopharmacology. 2 (suppl. 1) S238•Stanley N, Fairweather DB, Hindmarch I. (1999) Sleep and antidepressants- The importance of healthy normal data. The International Journal of Neuropsychopharmacology. 2 (suppl. 1) S80•Stanley N, Hindmarch I, Fairweather DB. (1999) Can Actigraphs measure the early onset of antidepressant action? The International Journal of Neuropsychopharmacology. 2(suppl. 1) S79•Stanley N, Hindmarch, I.(1999) Actigraphy can measure antidepressant induced daytime sedation in healthy volunteers. The International Journal of Neuropsychopharmacology. 2(suppl. 1) S40•Rigney U, Stanley N, Briley M, Hindmarch I. (1999) Pharmacodynamics of milnacipran in you and elderly volunteers. The International Journal of Neuropsychopharmacology. 2(suppl. 1) S35•Stanley N, Kimber S, Fairweather DB, Hindmarch I. (1998) Venlafaxine and dothiepin in depressed elderly patients: a comparison of efficacy and effects on cognition. European Neuropsychopharmacology8 (suppl. 2) S148•Stanley N, Fairweather DB, Hindmarch I. (1998) Actigraphy in Psychopharmacology. Psychiatria Danubina10(3) 317•Shamsi Z, Stanley N, Fairweather DB, Hindmarch I. (1998). The effects of fexofenadine on cognitive function and psychomotor performance. Psychiatria Danubina10 (3) 304•Rigney U, Stanley N, Briley M, Hindmarch I. (1998) Pharmacodynamics of milnacipran in elderly volunteers. Psychiatria Danubina10 (3) 316•Kimber S, Stanley N, Fairweather DB, Hindmarch I. (1998) Venlafaxine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition. Journal of Psychopharmacology 12 (Suppl 3), A:21•Fairweather DB, Stanley, N, Hindmarch I. (1997) Fluoxetine and dothiepin in depressed patients: A comparison of efficacy and effects on cognition and subjective sleep. European Neuropsychopharmacology7(suppl. 2) S148•Stanley N, Fairweather, DB, Hindmarch I. (1997) The effects of fluoxetine and dothiepin on twenty four hour activity in depressed patients. European Neuropsychopharmacology7 (suppl. 2) S171•Stanley N. Fairweather DB, Hindmarch I. (1997). The effects of Zemaphyte on activity and psychomotor performance in healthy subjects.Journal of Psychopharmacology 11 (Suppl 3), A:62•Shamsi Z, Parkin C, Fairweather DB, Stanley N, Hindmarch I. (1997) The effects of Cigarette smoking on overnight performance. Journal of Psychopharmacology 11 (Suppl 3), A:63•Stanley N, Hindmarch I. (1996). The measurement of daytime sedation using actigraphs. Journal of Psychopharmacology 10 (Suppl 3), A:21•Stanley N, Shamsi Z, Hindmarch I. (1996) The over estimation of sleep by actigraphs. Journal of Psychopharmacology 10 (Suppl 3), A:21•Shamsi Z, Stanley N, Hindmarch I. (1996) The First Night Effect: Environmental, Instrumental or a Combination of Both? Journal of Psychopharmacology 10 (Suppl 3), A:21•Shamsi Z, Stanley N, Hindmarch I. (1995) The effects of 3 doses of IPA on sleep & morning after performance of healthy volunteers.Journal of Psychopharmacology (Suppl), A:21Book ReviewsSept 2005 13 Dreams Freud Never had. By J. Allan Hobson. Times Higher Education SupplementMar 2001 Handbook of sleep medicine. by John M. Shneerson. Human Psychopharmacology: Clinical & Experimental, Vol. 16 Issue 2, p196Commissioned articlesOct 2005 Primary Sleep Disorders. GP MagazineNov. 2000 Zaleplon: advance in the treatment of insomnia. Prescriber Magazine 11 (22).Refereeing•NHRA•Arthritis Research Council •British Academy •British Journal of Rheumatology•BMC Nursing•BMC Endocrine Disorders•BMCF Medical Education•Current Medical Research & Opinion•Economic and Social Research Council •European Journal of Clinical Investigation •European Urology •Expert Opinion on Emerging Drugs •Expert Opinion on Therapeutic Patents •Human Psychopharmacology •Journal of Clinical Psychopharmacology •Journal of Psychopharmacology •Journal of Reproductive and Infant Psychology •Medical Informatics and the Internet in Medicine •Neuropsychobiology•Physiology and Behaviour •Psychiatry Research •Psychopharmacology •Scientific Reports•Discover PsychologyPoster Presentations•Dec 2005 American College of Neuropsychopharmacology. Hawaii - Is translational research monkey business: The journey of a Novel AMPAKINE (CX717) from primate to a human phase IIA study with a cognitive impairment model. •Dec 2005 American Society for Health System Pharmacists: Midyear Clinical Meeting. Las Vegas - Zolpidem modified-release formulation has greater persistence of activity compared to standard zolpidem in a pharmacodynamics model assessing the return to sleep following nocturnal awakening. •Nov 2005 U.S. Psychiatric & Mental Health Congress. Las Vegaso1) Zolpidem Modified-Release improves sleep continuity compared with standard zolpidem in a traffic noise model that induced sleep difficulty.o2) Effects of Zolpidem Modified-Release 6.25 mg and 12.5 mg on next-day psychomotor and cognitive performance in healthy elderly volunteers.o3) Effects of Zolpidem Modified-Release 12.5 mg on next-day psychomotor and cognitive performance in healthy adult volunteers.o4) Zolpidem Modified-Release has greater persistence of activity compared to standard zolpidem in a pharmacodynamics model assessing the return to sleep following nocturnal awakening. •June 2005 Associated Professional Sleep Societies 19th Annual Meeting. Denvero1) Effect of zolpidem modified-release formulation on next-day psychomotor and cognitive performance in a double-blind crossover study in healthy adult volunteers.o2) Effect of zolpidem modified-release formulation on next-day psychomotor and cognitive performance in a double-blind crossover study in healthy adult volunteers o3) Zolpidem Modified-Release significantly reduces latency to persistent sleep 4 and 5 hours post-dose compared with standard zolpidem in a model assessing the return to sleep following nocturnal awakening•May 2005 American Psychiatric Association Atlanta. - Zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem in a pharmacodynamics model assessing the return to sleep following nocturnal awakening.•March 2005 American Society for Clinical Pharmacology and Therapeutics Annual meeting, Orlandoo1)Effects of a new zolpidem modified-release formulation on next-day psychomotor and cognitive performance in two double-blind crossover studies in healthy adult and healthy elderly volunteers.o2) A randomized double-blind placebo-controlled 3-way crossover study investigating psychomotor and cognitive residual effects of a new zolpidem modified-release formulation in healthy volunteers.•June 2004 Associated Professional Sleep Societies 17th Annual Meeting, Philadelphia- A randomised double-blind placebo-controlled 10-way cross-over study shows that a new zolpidem modified release formulation improves sleep maintenance compared to standard zolpidem.•June 2004 XXIVst Collegium International Neuro-Psychopharmacologicum Congress, Pariso1) Later life and the use of sleep aids: Results from a large scale o2) An experimental method of evaluating duration of hypnotic effect. •Sept 2003 16th European College of Neuropsychopharmacology. Prague - The effects of a putative novel anxiolytic, LY544344, on objective and subjective measures of sleep in healthy volunteers. •Sept 2003 British Sleep Society 15th Annual Scientific Meeting. Cambridgeo1) Effect of acute normobaric hypoxia upon sleep characteristics in recreational athletes.o2) Acute normobaric hypoxia and its effects on measures of sleep quality in recreational athletes.o3) Nocturnal respiratory events during sleep at a simulated altitude of 2,500m in recreational athletes.o4) The effect upon cognitive and psychomotor function of acute normobaric hypoxia in recreational athletes•Sept. 2003 4th congress of The European Federation of the International Association for the study of pain chapters. Prague - Pregabalin, a novel alpha2-delta ligand for the treatment of neuropathic pain, show evidence of positive cognitive and psychomotor profile in healthy volunteers. •June 2003 Associated Professional Sleep Societies 17th Annual Meeting, Chicagoo1) Nocturnal respiratory events during sleep at a simulated altitude of 2,500m in recreational athletes.o2) Central arousal response to an experimental model of sleep disruption in healthy adults. o3) Evaluation of the sleep-activity profile of pregabalin compared with alprazolam in normal volunteers o4) Acute normobaric hypoxia and its effects on measures of sleep quality in recreational athletes. o5) The effects of rumination about work issues during leisure time on sleep: A two day diary study •May 200350th Annual Meeting of the American College of Sports Medicine. San Francisco.,o1) Acute normobaric hypoxia and its effects on measures of sleep quality in recreational athletes. o2) Nocturnal respiratory events during sleep in acute normobaric hypoxia in recreational athlete o3) Effect of acute normobaric hypoxia on cognitive and psychomotor function in recreational athletes •Feb 2003 The 13th International Hypoxia Symposium Banff - Sleep characteristics in acute normobaric hypoxia in recreational athletes •March 2003 American Pain Society, Chicago - Evaluation of cognitive and psychomotor profile of pregabalin in normal volunteers. •May 2002 155th American Psychiatric Association Annual Meeting Philadelphiao1) Evaluation of the cognitive and psychomotor profile of pregabalin compared to alprazolam in normal volunteerso2) Evaluation of the sleep-activity profile of pregabalin compared to alprazolam in normal volunteers•Dec. 2001 40th American College of Neuropsychopharmacology Annual Meeting, Hawaii - The effect of pregabalin (CI-1008), alprazolam and placebo on cognitive psychomotor function, car driving and aspects of sleep in healthy volunteers. •Sept. 2001 British Sleep Society 14th Annual Scientific Meeting. Cambridgeo1) The usefulness of amitriptyline as a hypnotico2) The residual effects of amitriptyline as a hypnotic.o3) Central and autonomic arousal response to an experimental model of insomnia in healthy adults.o4) An Experimentally induced model of insomnia: Technical aspects.o5) New technology and a dormant law: how a novel sleep watch may assist in the debate surrounding sleep deprived drivers and the law. •Sept 2000 13th European College of Neuropsychopharmacology. Munich -Comparison of the residual effects of zaleplon and zolpidem after administration during the night.•June 2000 Associated Professional Sleep Societies 14th Annual Meeting, Las Vegas - The accuracy of Mini-Motionlogger and Actiwatch in the identification of sleep as compared to sleep EEG. •Sept. 1999 12th European College of Neuropsychopharmacology. London.o1) Moclobemide and sleep.o2) The measurement of daytime ‘sleep -like’ activity using actigraphs.•Aug 1999XI World Congress of Psychiatry, Hamburg - Venlafaxine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition•May 1999 152nd American Psychiatric Association Annual Meeting Washington D.C. - Venlafaxine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition. •Nov. 1998 11th European College of Neuropsychopharmacology. Paris - Venlafaxine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition.•Oct. 1998British Sleep Society 10th Annual Scientific Meeting. Liverpool - Sleep and antidepressants- the importance of data from studies in normals. •Aug. 1998 8th Central European Neuropsychopharmacological Symposium, Vienna.o1) Actigraphy in psychopharmacologyo2) The effects of fexofenadine on cognitive function and psychomotor performanceo3) Pharmacodynamics of milnacipran in elderly volunteers•July. 1998British Association for Psychopharmacology, Cambridge - Venlafaxine and dothiepin in depressed patients: a comparison of efficacy and effects on cognition. •July. 1998XXIst Collegium International Neuro-Psychopharmacologicum Congress, Glasgow.o1) Actigraphs can measure antidepressant induced daytime sedation. o2) Can actigraphs measure the early onset of antidepressant action? o3) Sleep and antidepressants- the importance of healthy normal data.o4) The pharmacodynamics of milnacipran in young and elderly Volunteerso5) The effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep qualityo6) The effects of fexofenadine on cognitive function and psychomotor performance•Oct. 1997British Sleep Society 9th Annual Scientific Meeting. Edinburgh - The role of PSG in a multi-disciplinary sleep disorder clinic.•Sept. 1997 10th European College of Neuropsychopharmacology. Vienna.o1) Fluoxetine and dothiepin in depressed patients: A comparison of efficacy and effects on cognition and subjective sleep. o2) The effects of fluoxetine and dothiepin on twenty four hour activity in depressed patients.•July 1997British Association for Psychopharmacology. Cambridge.o1) The effects of Zemaphyte on activity and psychomotor performance in healthy subjects.o2) The effects of Cigarette smoking on overnight performance •July 1996British Association for Psychopharmacology, Cambridgeo1) The measurement of daytime sedation using actigraphs. o2) The over estimation of sleep by actigraphs. o3) Effects of fluoxetine and dothiepin on cognition and sleep in depressed patients o4) The First Night Effect: Environmental, Instrumental or a Combination of Both?•July 1995British Association for Psychopharmacology Cambridge - The effects of 3 doses of IPA on sleep & morning after performance of healthy volunteers. •April 1995Sleep & Pleasure. ARISE Workshop, Amsterdam